Ownership history in CITIGROUP INC · 127 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in SAREPTA THERAPEUTICS COM (SRPT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,146,175 | +1,111,175 | +3174.8% | 0.01% | $24.7M | $21.52 |
| 2025 Q3 | REDUCED | 35,000 | -983,922 | -96.6% | 0.00% | $674K | $19.27 |
| 2025 Q3 | ADDED | 1,018,922 | +1,001,422 | +5722.4% | 0.01% | $19.6M | $19.27 |
| 2025 Q2 | UNCHANGED | 17,500 | — | 0% | 0.00% | $299K | $17.10 |
As of 2025 Q4 — sorted by position size